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Objectives: to assess whether the risk of recurrent ischaemic stroke in patients with symptomatic internal carotid artery
(ICA) occlusion has changed over the past decades, to determine risk factors for the occurrence of ischaemic stroke and
to assess the risk of endarterectomy (CEA) of a severe contralateral ICA stenosis.
Design: retrospective cohort study.
Patients and methods: patients with symptomatic ICA occlusion were identified from duplex registry files between
1991 and 1995. Information was obtained on vascular risk factors, performance of CEA for a contralateral ICA stenosis
and on recurrence of ischaemic stroke. The rate of complications occurring within 30 days after CEA of the contralateral
ICA in patients with symptomatic ICA occlusion was compared with the risk of CEA in patients with asymptomatic
ICA occlusion and severe contralateral ICA stenosis (symptomatic or asymptomatic).
Results: ninety-seven patients were identified. Mean follow-up time was 26 months. The annual risk of (non-)fatal stroke
was 5.3% for all strokes (95% CI 2.9%–9.6%) and 3.8% for ipsilateral stroke (95% CI 1.9%–7.7%). Hyperlipidaemia
and severe stenosis of the contralateral ICA were independent risk factors. Twenty-two of 32 patients with a severe
stenosis of the contralateral ICA underwent CEA, of which one patient died and three suffered a minor ischaemic stroke.
The perioperative risk of CEA in the control group of 20 patients with asymptomatic contralateral ICA occlusion was
0% (0 of 20).
Conclusions: outcome in patients with symptomatic ICA occlusion has not substantially improved over the years. CEA
for severe stenosis of the contralateral ICA carried a relatively high risk in our series, but deserves to be studied in a
controlled design.
Key Words: Carotid artery occlusion; Outcome; Carotid endarterectomy.
Introduction that there might still be a role for EC/IC bypass
surgery in a highly selected group of patients, based on
Patients with symptoms of cerebral or retinal isch- the assumption that in some patients a compromised
cerebral blood flow plays a role in causing transientaemia associated with ipsilateral occlusion of the in-
ternal carotid artery (ICA) have an annual risk of 5–8% ischaemic attacks (TIAs) and ischaemic stroke.1,4–6 In
this light, outcome in patients with symptomatic ICAof recurrent ischaemic stroke.1,2 In 1985 the results
of the extracranial–intracranial (EC/IC) bypass study occlusion regains interest. Therefore, we studied the
rate of recurrent ischaemic stroke and other vascularshowed that superficial temporal artery to middle
cerebral artery (MCA) bypass surgery does not prevent events in a consecutive series of patients to determine
if outcome has improved over the last decade, ir-recurrent ischaemic stroke in these patients.3 Con-
sequently, the only treatment available for these respective of the haemodynamic state of the brain.
This is important, because the possible risk of EC/ICpatients is that applied in all patients with symp-
tomatic atherosclerotic disease, e.g. antithrombotic bypass surgery has to be weighed against the risk of
recurrent stroke with the treatment currently con-drugs and modification of risk factors for athero-
sclerosis. Over recent years, evidence has accumulated sidered optimal, e.g. antithrombotic medication, treat-
ment of risk factors and probably CEA in case of
severe stenosis of the contralateral ICA or the ip-
∗ Please address all correspondence to: C. J. M. Klijn, Department silateral external carotid artery (ECA). In addition, riskof Neurology, University Medical Center Utrecht, P.O. Box 85500,
3508 GA Utrecht, The Netherlands. factors for ischaemic stroke and vascular events were
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studied. Furthermore, we compared the risk of CEA Occurrence of outcome events within 30 days of
CEA of the contralateral ICA was considered a com-for severe stenosis of the contralateral ICA in these
patients with that of CEA in patients with an asympto- plication of surgery. Complications associated with
CEA in the study cohort were compared with com-matic ICA occlusion and a contralateral ICA stenosis
(symptomatic or asymptomatic). plications associated with CEA in patients with
asymptomatic ICA occlusion and a (symptomatic or
asymptomatic) severe stenosis of the contralateral ICA.
Patients in this control group were identified from the
Patients, Control Subjects and Methods same duplex registry in the same time period. Reports
of surgical procedures were reviewed for use of an
Patients with an occlusion of one or both ICAs were intraoperative shunt.
selected from the registry of all duplex investigations CT or MRI scans of the brain performed at baseline
of the carotid arteries performed in the vascular and in case of an outcome event were independently
laboratory of the University Medical Center Utrecht, reviewed by two of the investigators (CJMK, LJK),
The Netherlands between 1991 and 1995. Records of blinded for clinical data and side and severity of ICA
222 patients with an occluded ICA were reviewed for stenosis. Subsequently, clinical details were examined
symptoms of cerebral or retinal ischaemia within 6 to assess if the scan abnormalities were related to the
months prior to the demonstration of the ICA occlusion patients’ symptoms or signs. Cerebral infarcts were
by two investigators (CJMK, PvB). Patients without categorised by the territories of the major cerebral
symptoms attributable to ischaemia in the vascular arteries involved (anterior cerebral artery (ACA), MCA
territory of the occluded ICA, patients with a diagnosis or posterior cerebral artery (PCA), (territorial infarcts)
of dissection of the ICA, patients with a history of or as being in the border-zone area between the ACA
radiotherapy in the region of the symptomatic ICA and and MCA, the MCA and PCA, between ACA and
patients with severe disability after stroke (modified MCA and PCA or between the deep and superficial
Rankin grade 4 or 5) were excluded. territory of the MCA (border-zone infarcts). Territorial
Records were reviewed for gender, age, presenting infarcts were further divided into end-zone infarcts,
symptoms, vascular risk factors, antithrombotic med- large subcortical infarcts and small deep (lacunar)
ication at the time of presenting symptoms, con- infarcts.
firmation of the occlusion of the ICA by angiography, Univariate analyses of risk factors for the primary
stenosis of the contralateral ICA and performance of and secondary outcome events were performed by
CEA of the contralateral ICA. Patients who underwent means of the Cox proportional hazards model resulting
EC/IC bypass surgery were included until the time in hazard ratios (HR) with 95% confidence interval
of surgery, while those patients who underwent CEA (CI). Variables with an at least borderline statistically
because of severe stenosis of the contralateral ICA significant (p<0.10) relationship with an outcome event
were followed until the end of the study period. were included in a multivariate model to determine
The primary outcome event was fatal or non-fatal potential independent contributors to prognosis.
ischaemic stroke. The secondary outcome event was
the composite event of (non-)fatal stroke (ischaemic
or haemorrhagic), (non-)fatal myocardial infarction,
vascular death from other causes (sudden death, con- Results
gestive heart failure, systemic bleeding, pulmonary
embolism) or retinal infarction, whichever happened Ninety-seven patients (mean age 64 years, range 40–81)
were identified. Twenty-two presented with cerebralfirst. The diagnosis of ischaemic stroke was made
when sudden and focal neurological deficits caused TIAs, 49 with minor ischaemic stroke, 19 patients
with transient monocular blindness (TMB) and sevenan increase in handicap of at least one grade on the
modified Rankin scale, which increase lasted for more patients with symptoms of chronic ocular ischaemia
(COI) alone. In 63 patients angiography was performedthan 24 hours, and when haemorrhage was excluded
by computed tomography (CT) or magnetic resonance to confirm the diagnosis of ICA occlusion established
by duplex investigation. Baseline characteristics areimaging (MRI). Non-fatal ischaemic stroke was clas-
sified as minor when the estimated modified Rankin shown in Table 1. At the time of their presenting
symptoms, 27 patients were treated with low-dosescore was Ζ3 and as major disabling when 4 or 5.
Information about outcome events on follow up was aspirin, nine patients were on oral anticoagulation
(AC) therapy and one patient was treated with bothobtained by telephone interviews with patients, their
relatives or their general practitioners. aspirin and AC.
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The history contained one or more haemodynamic sequently underwent a CEA without any com-
plications. One of the two remaining patients hadfeatures in the presenting symptoms of 19 of 97
patients. Nine patients reported that their symptoms bilateral ICA occlusion, and only one of the 11 patients
who suffered a recurrent stroke did not have a stenosiswere related to rising from a lying or sitting position,
in two patients symptoms were related to physical or occlusion of the contralateral ICA.
Of the 11 patients with recurrent strokes the CT orexercise, 6 patients had symptoms consistent with limb
shaking7–9 and 5 with retinal claudication.10,11 In two MRI of the brain was available for revision in 9. Four
patients showed border-zone infarction, 2 between thepatients symptoms were related to low blood pressure
and one patient had symptoms subsequent to com- vascular territories of the MCA and PCA, 1 between
the vascular territories of all three major cerebral ar-pression of the contralateral carotid artery during
transcranial Doppler investigation. In six patients two teries and 1 between the vascular territories of the
ACA and MCA. One of these four patients had anof these features occurred together.
Mean follow-up time was 25.7 months (median 24.0; infarct in the territory of the ACA in addition to that
in the border-zone area. Three patients had infarcts inrange 0.5–70.5). Follow-up was incomplete in only one
patient, as he could not be traced after having moved the territory of the MCA; two were partial end-zone
infarcts, one a large subcortical infarct. Two patientsabroad. All patients were treated according to standard
clinical practice, e.g. with antithrombotic agents (low- did not show a recent infarct on the CT of the brain,
in both cases performed within 48 hours of onset ofdose aspirin in the majority of patients) and modi-
fication of risk factors. symptoms.
Seven patients died of vascular causes other thanThirty-two patients had a severe ([70%, based on
Doppler criteria) stenosis of the contralateral ICA, that ischaemic stroke (six of myocardial infarction, one of
stroke of undetermined type) and six patients sufferedwas symptomatic in five. Twenty-two of the 32 patients
underwent CEA. Ten patients were not operated on non-fatal myocardial infarction. Retinal infarction was
not observed. Five more patients died, four of cancerbecause the physician involved did not recommend
the procedure (six patients, one of whom had COI and one of urosepsis. The annual risk of ischaemic
stroke (fatal or non-fatal) was 5.3% for all strokes (95%alone), because the patient refused the operation (two
patients) or because EC/IC bypass surgery was ad- CI 2.9–9.6%) and 3.8% for ipsilateral ischaemic stroke
(95% CI 1.9–7.7%). The annual risk of the combinedvised (one patient). The tenth patient was scheduled
for CEA, but suffered a minor stroke before the oper- vascular outcome event of death from any vascular
cause, non-fatal stroke or non-fatal MI was 10.7% (95%ation took place. Shortly after the event this patient
was operated on. Two further patients underwent CEA CI 7.0–16.4%).
of a severe stenosis of the ipsilateral ECA.
Risk factors
Outcome
The results of the univariate analyses of risk factors
During the time of follow-up 11 patients suffered for the primary and secondary outcome event are
a recurrent ischaemic stroke, eight of which were shown in Table 1. A severe contralateral stenosis of
ipsilateral to the symptomatic occluded ICA (Table 2). the ICA, hyperlipidaemia and smoking were identified
All 11 patients had been seen by a neurologist at the as risk factors for recurrent ischaemic stroke. Multi-
time of the recurrent stroke and all patients were variate analysis showed that a history of hyper-
using antithrombotic medication: low-dose aspirin in lipidaemia (hazard ratio (HR) 5.0; 95% CI 1.2–20.0%)
9 patients, aspirin and dipyridamole in one patient and severe contralateral stenosis of the ICA (HR 12.6;
(number 10) and one other patient (number 9) was 95% CI 2.6–61.7%) independently increased the risk of
treated with heparin. Four strokes (three minor, one recurrent ischaemic stroke. A history of heart disease
fatal) occurred within 30 days of CEA of the contra- (HR 4.5; 95% CI 1.8–11.2%) and smoking (HR 1.4; 95%
lateral ICA, in fact within the first day of surgery. CI 1.1–1.7%) were independent determinants for the
Patients 9 and 10 suffered a recurrent ipsilateral stroke occurrence of any vascular event.
6.5 and 3.5 months after their presenting symptoms,
despite the fact that they underwent CEA of their
severe stenosis of the contralateral ICA. Three strokes Risk of CEA of the contralateral ICA
(patients 3, 4 and 6) occurred in the group of 10
patients who had a severe contralateral ICA stenosis Of the 22 patients who underwent CEA of a severe
stenosis contralateral to the symptomatic ICA oc-but were not operated on; patients 4 and 6 sub-
Eur J Vasc Endovasc Surg Vol 19, June 2000
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clusion, four (18%; 95% CI 5–40%) had a perioperative high, e.g. 8 of 11 (73%). In the literature, information
stroke. In one of these (patient 7) the hemisphere on the severity of the recurrent strokes is rarely given.
ipsilateral to the operated side had also given rise to Information on the prognostic value of risk factors for
ischaemic symptoms and the infarct occurred on that atherosclerosis for recurrent vascular events in patients
side. In 16 of the 22 operations (73%; 95% CI 50–89%) with symptomatic ICA occlusion is scarce. In two recent
a shunt was used because of changes in the EEG after studies in patients with symptomatic ICA occlusion,
clamping of the carotid artery. The group of 22 CEAs age, but no other cardiovascular risk factor in-
does not include the two CEAs performed (without dependently predicted recurrent stroke.6,15 Another
complications) in patients 4 and 6 after a recurrent study found that a high systolic blood pressure in-
ischaemic stroke (Table 2). creased the chance of recurrent stroke and that anti-
A control group of 20 patients underwent CEA of hypertensive treatment diminished this chance.14 A
a severe stenosis of the ICA in the presence of an high haemoglobin concentration, a prognostic factor for
asymptomatic contralateral ICA occlusion. Ten recurrent ischaemic stroke in the general population in
patients had symptoms of the hemisphere or retina the Framingham study,16 had no predictive value in the
ipsilateral to the side of the stenosis and 10 patients medically treated patients randomised in the EC/IC
were completely asymptomatic. In 10 of these 20 bypassstudy.17 Althoughwerealise that theresults from
patients (50%; 95% CI 27–73%) a shunt was needed. the multivariate analysis in our study are based on rel-
No complications (0%; 95% CI 0–17%) occurred within atively few endpoints as reflected in the rather wide
30 days of surgery. 95% CIs, it is of interest that we found that hyper-
The absolute difference in complication risk after lipidaemia and a severe stenosis of the contralateral ICA
CEA in the presence of a contralateral ICA occlusion were independent risk factors for recurrent stroke in
between patients with and without symptoms at- patients with symptomatic ICA occlusion, whereas a
tributable to the occluded ICA was 18% (95% CI history of heart disease and smoking were in-
2–34%). A shunt tended to be applied more often in dependently associated with any subsequent vascular
patients with symptomatic ICA occlusion (RR 1.5; 95% event. We did not study haemoglobin concentration.
CI 0.9–2.4%). Hypertension could not be shown to be a risk factor for
recurrent ischaemic stroke, probably because it was so
common in the entire group of patients. The presence
of an infarct in a border-zone area as a predictor ofDiscussion
poor outcome has been described,18 but could not be
confirmed in our study. The number of border-zoneThis study shows that the annual risk of recurrent
infarcts as presenting stroke was 13 of 97 (13%) in ourischaemic stroke in patients with symptomatic ICA
series, compared with 8 of 154 (5%) in the series pub-occlusion has not improved over the years. We found
lished byBogousslavsky and Regli.18 CT-proven border-an annual risk of recurrent ischaemic stroke of 5.3%
zone infarcts accounted for 72% (18 of 25) of recurrent(95% CI 2.9–9.6%) and of recurrent ipsilateral ischaemic
strokes (all ipsilateral) in their study, whereas in ourstroke of 3.8% (95% CI 1.9–7.7%), which correspond
series 44% (four of nine) of CT-proven recurrent strokeswith the 5.5% (95% CI 5.0–6.0%) and 2.1% (95% CI
were of the border-zone type (two ipsi- and two contra-1.6–2.8%) which were found in a review of 20 studies
lateral). Haemodynamic features of presenting symp-published between 1961 and 1986.1 The annual stroke
toms were not associated with increased risk of arisk found in other recent studies on the outcome of
recurrent vascular event. This is in accordance with thepatients with symptomatic ICA occlusion may be less
observations in a prospective study of 34 medicallyreliable, because most of these included measurements
treated patients with bilateral ICA occlusion.19 Patientsof cerebral blood flow or cerebrovascular reserve cap-
with ICA occlusion have lower cerebral blood flow/acity.6,12–15 This may have caused selection bias in that
cerebral blood volume ratios when studied with pos-patients perceived to be at high risk of recurrent stroke
itron emission tomography (PET)20 and worse MCAmay have been more readily referred for ancillary
blood flow reactivity measured with PET after inducedinvestigations. Our study has the limitations inherent
hypercapnia,21 but to date no prospective follow-upto the retrospective design, but the inclusion criteria
study is available in which haemodynamic aspects ofwere stricter than in most previous studies in that
symptoms in patients with unilateral ICA occlusion arewe included only patients with signs and symptoms
shown to have predictive value for recurrent stroke orattributable to the brain or eye on the side of the
other vascular events. Because of the retrospective de-ICA occlusion. In the current study the proportion of
recurrent strokes that were minor disabling was rather sign of our study, the presence of haemodynamic symp-
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toms may have been underestimated. In concordance case decades ago, and that patients now are routinely
treated with antithrombotic drugs, outcome in patientswith the results from a recent prospective study,6 the
with symptomatic ICA occlusion has not substantiallyrecurrence of presenting symptoms after the ICA oc-
improved over recent decades. This information isclusion was documented had no predictive value for
important in the design of new studies to evaluaterecurrent stroke in our series. A compromised cerebral
therapeutic strategies in these patients. CEA of severeblood flow identified by PET,6,13 by transcranial Doppler
stenosis of the contralateral ICA carried a relativelywith carbon dioxide challenge22 or by stable xenon CT
high risk, but may still be a useful therapy and needswith acetazolamide23 has been shown tobe an important
to be studied in a controlled design.prognostic factor for recurrent ischaemic stroke in
patients with symptomatic ICA occlusion, but was not
studied in our retrospective series.
The presence of a severe stenosis of the contralateral
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